{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:43:32Z","timestamp":1792215812242,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clinre.2026.102888","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:38:31Z","timestamp":1784936311000},"page":"102888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative study of nintedanib versus conventional drugs in the treatment of inflammatory bowel disease-associated intestinal fibrosis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0611-5527","authenticated-orcid":false,"given":"Meng","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2026.102888_bib0001","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1751-2980.13022","article-title":"Intestinal stricture in Crohn\u2019s disease: a 2020 update","volume":"22","author":"Lin","year":"2021","journal-title":"J Dig Dis"},{"key":"10.1016\/j.clinre.2026.102888_bib0002","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1089\/lap.2021.0099","article-title":"Managing stricturing Crohn\u2019s disease: resect? Strictureplasty? Dilate?","volume":"31","author":"Lowenfeld","year":"2021","journal-title":"J Laparoendosc Adv Surg Tech"},{"key":"10.1016\/j.clinre.2026.102888_bib0003","first-page":"1283","article-title":"Can we prevent, reduce or reverse intestinal fibrosis in IBD?","volume":"17","author":"Latella","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clinre.2026.102888_bib0004","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2026.102888_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0005-2020","article-title":"The adoption of nintedanib in systemic sclerosis: the SENSCIS study","volume":"16","author":"Bruni","year":"2020","journal-title":"Breathe"},{"key":"10.1016\/j.clinre.2026.102888_bib0006","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinre.2026.102888_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3867198","article-title":"Effects of nintedanib in an animal model of liver fibrosis","volume":"2020","author":"Wollin","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clinre.2026.102888_bib0008","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab Investig; J Tech Methods Pathol"},{"key":"10.1016\/j.clinre.2026.102888_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14491-5","article-title":"Nintedanib regulates intestinal smooth muscle hyperplasia and phenotype in vitro and in TNBS colitis in vivo","volume":"12","author":"Kataria","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2026.102888_bib0010","series-title":"Myofibroblasts","first-page":"385","article-title":"Mouse models of intestinal fibrosis","volume":"2299","author":"Li","year":"2021"},{"key":"10.1016\/j.clinre.2026.102888_bib0011","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1111\/jcmm.16518","article-title":"Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis","volume":"25","author":"Liu","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.clinre.2026.102888_bib0012","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00161-2019","article-title":"Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases","volume":"54","author":"Wollin","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinre.2026.102888_bib0013","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","article-title":"A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models","volume":"43","author":"Ren","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.clinre.2026.102888_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adx0368","article-title":"Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis","volume":"18","author":"Yashaswini","year":"2026","journal-title":"Sci Transl Med"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:16:57Z","timestamp":1792214217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2210740126001348"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102888","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of nintedanib versus conventional drugs in the treatment of inflammatory bowel disease-associated intestinal fibrosis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102888"}}